I think we've seen the media reports that the pharmaceutical industry offered the Canadian government $1 billion to delay bringing the PMPRB reforms in. According to an industry estimate, they say the regulations would reduce drug companies' revenues by about $19.8 billion over 10 years.
Do you think the opposition of the pharmaceutical industry to these reforms is based more on their interest in their own profits or on their concern that Canadian patients won't get access to drugs?